Biomimetics or biomimicry is the emulation of the models, systems, and elements of nature to solve complex human problems. Biomimetics has given rise to new technologies inspired by biological solutions at macro and nanoscales. Biomimetics is used for the development of biocompatible material which allows healthcare professionals to monitor and treat chronic diseases such as cardiovascular disorders. Biomimetics has applications in regenerative medicine, tissue engineering, and drug delivery. The incorporation of nanotechnology played a pivotal role in the application of bone structures as well as drug delivery systems.
Market Dynamics
The increasing incidence of cardiovascular disorders, demand for prosthetics, implants for an organ transplant, adoption of expansion strategies by manufacturers, and product launches, along with the rising healthcare expenditure in developed and developing economies are the major factors driving the global medical biomimetic market growth. For instance, according to the American Medical Association- a professional association and lobbying group of physicians and medical students, public health activity resulted in medical spending of US$ 238.3 billion in 2020 and reached around US$ 238.3 bn in 2021 in the U.S.
Key features of the study:
- This report provides in-depth analysis of the global medical biomimetic market and provides market size (US$ billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
- It profiles key players in the global medical biomimetic market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study are AVINENT Science and Technology, SynTouch Inc., Wright Medical Group N.V., EPS Vascular, Varian Medical Systems, Inc., and Vandstorm, Inc.
- Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global medical biomimetic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical biomimetic market.
Detailed Segmentation:
- Global Medical Biomimetics Market, By Product Type:
- Cardiovascular
- Ophthalmology
- Dental
- Orthopedic
- Others
- Global Medical Biomimetics Market, By Application:
- Wound Healing
- Plastic Surgery
- Drug Delivery
- Others
- Global Medical Biomimetics Market, By Region:
- North America
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- AVINENT Science and Technology
- SynTouch Inc.
- Wright Medical Group N.V
- EPS Vascular
- Varian Medical Systems, Inc.
- Vandstorm, Inc.
